Reports have indicated that WASF3 expression is associated with poor prognosis and is a potential prognostic factor for gastric cancer patients, therefore, targeting WASF3 is a novel potential therapeutic strategy for gastric cancer (18, 19). Here, WASF3 is linked to gastric cancer.